DE50311665D1 - Guanidinophenylalanin-verbindungen als urokinase-inhibitoren - Google Patents

Guanidinophenylalanin-verbindungen als urokinase-inhibitoren

Info

Publication number
DE50311665D1
DE50311665D1 DE50311665T DE50311665T DE50311665D1 DE 50311665 D1 DE50311665 D1 DE 50311665D1 DE 50311665 T DE50311665 T DE 50311665T DE 50311665 T DE50311665 T DE 50311665T DE 50311665 D1 DE50311665 D1 DE 50311665D1
Authority
DE
Germany
Prior art keywords
guanidinophenylalanine
compounds
urokinase inhibitors
urokinase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50311665T
Other languages
English (en)
Inventor
Stefan Sperl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heidelberg Pharma AG
Original Assignee
Wilex AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wilex AG filed Critical Wilex AG
Priority to DE50311665T priority Critical patent/DE50311665D1/de
Application granted granted Critical
Publication of DE50311665D1 publication Critical patent/DE50311665D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
DE50311665T 2002-06-11 2003-06-05 Guanidinophenylalanin-verbindungen als urokinase-inhibitoren Expired - Lifetime DE50311665D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE50311665T DE50311665D1 (de) 2002-06-11 2003-06-05 Guanidinophenylalanin-verbindungen als urokinase-inhibitoren

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10225876A DE10225876A1 (de) 2002-06-11 2002-06-11 Guanidinophenylalaninverbindungen als Urokinase-Inhibitoren
PCT/EP2003/005918 WO2003103644A2 (de) 2002-06-11 2003-06-05 Guanidinophenylalaninverbindungen als urokinase-inhibitoren
DE50311665T DE50311665D1 (de) 2002-06-11 2003-06-05 Guanidinophenylalanin-verbindungen als urokinase-inhibitoren

Publications (1)

Publication Number Publication Date
DE50311665D1 true DE50311665D1 (de) 2009-08-13

Family

ID=29594375

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10225876A Withdrawn DE10225876A1 (de) 2002-06-11 2002-06-11 Guanidinophenylalaninverbindungen als Urokinase-Inhibitoren
DE50311665T Expired - Lifetime DE50311665D1 (de) 2002-06-11 2003-06-05 Guanidinophenylalanin-verbindungen als urokinase-inhibitoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10225876A Withdrawn DE10225876A1 (de) 2002-06-11 2002-06-11 Guanidinophenylalaninverbindungen als Urokinase-Inhibitoren

Country Status (7)

Country Link
US (1) US7538216B2 (de)
EP (1) EP1511721B1 (de)
AT (1) ATE435200T1 (de)
AU (1) AU2003236701A1 (de)
DE (2) DE10225876A1 (de)
ES (1) ES2325576T3 (de)
WO (1) WO2003103644A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50310038D1 (de) * 2002-03-11 2008-08-07 Curacyte Ag Hemmstoffe der urokinase, ihre herstellung und verwendung
DE10301300B4 (de) * 2003-01-15 2009-07-16 Curacyte Chemistry Gmbh Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein
DE10342108A1 (de) * 2003-09-11 2005-04-14 Curacyte Chemistry Gmbh Basisch-substituierte Benzylaminanaloga als Inhibitoren des Gerinnungsfaktors Xa, ihre Herstellung und Verwendung
DE102004045720A1 (de) * 2004-09-21 2006-03-23 Wilex Ag Stabile Dosierungsform von Phenylalanin-Derivaten
DE602006009257D1 (de) 2005-06-24 2009-10-29 Wilex Ag Verwendung von urokinase-inhibitoren zur behandlunklerose (als)
DE102006050672A1 (de) * 2006-10-24 2008-04-30 Curacyte Discovery Gmbh Hemmstoffe des Plasmins und des Plasmakallikreins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2073776A1 (en) * 1990-11-15 1992-05-16 Joerg Stuerzebecher Meta-substituted phenyl alanine derivatives
DE59903981D1 (de) 1998-07-20 2003-02-13 Wilex Ag Neue urokinase-inhibitoren
ES2188003T3 (es) * 1998-09-18 2003-06-16 Pentapharm Ag Inhibidores de la uroquinasa.
DE19940389A1 (de) 1999-08-25 2001-03-01 Wilex Biotechnology Gmbh Selektive Inhibitoren des Urokinase-Plasminogen Aktivators
DE10013715A1 (de) 2000-03-20 2001-09-27 Wilex Biotechnology Gmbh Hochselektive Inhibitoren des Urokinase-Plasminogenaktivators
DE10029014A1 (de) 2000-06-15 2001-12-20 Univ Schiller Jena Urokinase-Hemmstoffe
ATE386029T1 (de) 2001-03-21 2008-03-15 Wilex Ag Urokinase-inhibitoren

Also Published As

Publication number Publication date
WO2003103644A3 (de) 2004-04-01
US20050267127A1 (en) 2005-12-01
US7538216B2 (en) 2009-05-26
AU2003236701A8 (en) 2003-12-22
ES2325576T3 (es) 2009-09-09
EP1511721A2 (de) 2005-03-09
AU2003236701A1 (en) 2003-12-22
DE10225876A1 (de) 2003-12-24
ATE435200T1 (de) 2009-07-15
EP1511721B1 (de) 2009-07-01
WO2003103644A2 (de) 2003-12-18

Similar Documents

Publication Publication Date Title
ATE499097T1 (de) Monozyklische heterozyklen als kinase-hemmer
DE60310576D1 (en) 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
HK1120209A1 (en) Use of fused heterocyclic compounds as scce inhibitors
EA200701467A1 (ru) Пирролидиновые ингибиторы иап (ингибиторов апоптоза)
ATE353217T1 (de) 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
DE60309848D1 (de) Purinderivate als kinaseinhibitoren
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
ATE420879T1 (de) Indolizine als kinaseproteinhemmer
RU2448096C3 (ru) Диарилгидантоины
UA116188C2 (uk) Інгібітори фосфатидилінозит-3-кінази і способи їх застосування
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
ATE542796T1 (de) N-sulfonylcarboximidamidverbindungen als apoptosepromotoren
ATE443044T1 (de) Tace inhibitoren
ATE435200T1 (de) Guanidinophenylalanin-verbindungen als urokinase- inhibitoren
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
CY1111289T1 (el) Συνθεσεις αναστολεων ογκου που περιεχουν νιτροακριδινη
TR200200169T2 (tr) IL-18 inhibitörlerinin kullanımı.
DE502005010237D1 (de) Stabile dosierungsform von phenylalanin-derivaten
DK1521752T3 (da) Makrocykliske forbindelser til behandling af cancer
DK1618116T3 (da) Ruthenium(II)-komplekser til behandling af tumorer
TW200602023A (en) Monocyclic heterocycles as kinase inhibitors
PT1461083E (pt) Terapia combinada contra tumores que compreende derivados de distamicina de acriloilo substituidos e de inibidores de proteina-quinase (serina/treonina-quinase)
DE60326488D1 (de) Zusammensetzungen die eine kombination von diphenylharnstoff impdh-hemmern und apoptose-induzierenden antikrebsmitteln enthalten
ATE364037T1 (de) Tryptasehemmer
ATE388710T1 (de) Phthalazinderivate als phosphodiesterase-4-hemmer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition